Pharma & Biotech - Page 6

Takeda Pharmaceutical’s long-serving research and development chief Andy Plump is set to retire, marking the end of a significant era for the Japanese drugmaker. Plump has been a central figure in shaping

The FDA’s Oncology Center of Excellence has a firm hand at the helm as Angelo de Claro commits to driving forward the centre’s regulatory mission. De Claro currently serves as Director of

Paysign, Inc. (PAYS) has developed a purpose-built large language model at the core of its ClaimGuardRx platform, targeting fraud and diversion in patient affordability programmes. Bryan Dennison, Senior Vice President of Sales

Paysign’s Vice President of Patient Affordability, Logan Melchione, says clients are consistently frustrated by the dual burden of diversion and fraud on their programmes. Both problems drain copay assistance programmes of critical

HDA’s Kala Shankle is urging wholesale distributors and third-party logistics providers not to wait for Washington before preparing for national licensure requirements. Shankle’s core message is that the work required ahead of

DHL Group is significantly expanding its Life Sciences and Healthcare capabilities in Singapore through a series of major infrastructure investments targeting the Asia Pacific market. The expansion builds on the earlier opening

Caris Life Sciences (NASDAQ: CAI) has launched a national advertising campaign called “Math,” starring award-winning actor, producer and director Kevin Costner. The campaign is designed to raise public awareness about the importance

The shift toward home-administered pharmaceutical therapies is accelerating, prompting organisations to fundamentally rethink how they guide patients through complex clinical transitions. Healthcare companies are under growing pressure to ensure patients feel equipped

Bayer HealthCare Pharmaceuticals has secured expanded FDA accelerated approval for sevabertinib, sold as Hyrnuo, targeting previously untreated HER2-mutated non-small cell lung cancer patients. The U.S. Food and Drug Administration granted the expanded